Noted for its strength in life sciences IP work, MLL Legal regularly acts for major pharma companies, medical device clients, and universities. Nicola Benz leads the team alongside the ‘excellent’ Simon Holzer, who is recognised for his deep knowledge of IP litigation within the pharma industry, and is noted for his experience in regulatory work. European patent attorney Ulrike Ciesla is known for her vast expertise in both contentious and non-contentious pharma patent work. Louisa Galbraith routinely appears before the Swiss Federal Administrative Court in cases concerning pricing orders from the Federal Office of Public Health, and appeals against Swissmedic decisions.
Legal 500 redaktioneller Kommentar

Anwält*innen

Leading partners

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Next Generation Partners

Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.

Praxisleitung

Nicola Benz; Simon Holzer

Weitere Kernanwält*innen

Ulrike Ciesla; Louisa Galbraith; Kilian Schärli